JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 13, 2004; DOI: 10.1124/jpet.103.061374


0022-3565/04/3091-285-292$20.00
JPET 309:285-292, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.061374v1
309/1/285    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pacifici, R.
Right arrow Articles by de la Torre, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pacifici, R.
Right arrow Articles by de la Torre, R.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Paroxetine Inhibits Acute Effects of 3,4-Methylenedioxymethamphetamine on the Immune System in Humans

Roberta Pacifici, Simona Pichini, Piergiorgio Zuccaro, Magí Farré, Mireia Segura, Jordi Ortuño, Simonetta Di Carlo, Antonella Bacosi, Pere N. Roset, Jordi Segura, and Rafael de la Torre

Istituto Superiore di Sanità, Rome, Italy (R.P., S.P., P.Z., S.D., A.B.); Institut Municipal d'Investigació Mèdica, Barcelona, Spain (M.F., M.S., J.O., P.N.R., J.S., R.d.l.T.); Universitat Pompeu Fabra, Barcelona, Spain (M.S., J.S., R.d.l.T.); and Universitat Autònoma, Barcelona, Spain (S.P., M.F., P.N.R.)

The effect of pretreatment with paroxetine on cell-mediated immune response and release of cytokines after the administration of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") was investigated in a double-blind, randomized, crossover, controlled clinical trial in which 12 healthy male recreational users of MDMA participated. Subjects received 20 mg/day paroxetine (or placebo) for the 3 days before MDMA challenge (100 mg). Acute MDMA administration produced a time-dependent decrease in CD4 T-helper cells, a decrease in the functional responsiveness of lymphocytes to mitogenic stimulation, a simultaneous increase in natural killer (NK) cells as well as cortisol and prolactin stimulation kinetics. A high increase in the release of anti-inflammatory cytokines (transforming growth factor-{beta} and interleukin-10) with a simultaneous decrease of anti-inflammatory response (interleukin-2) was also observed. Pretreatment with paroxetine partially reduced MDMA effects on CD4 T and NK cells, whereas totally inhibiting the suppression of the immune response to mitogens and alterations in cytokines release. MDMA-induced alterations in the immune system as well as antagonistic effects mediated by paroxetine show a trend toward baseline levels at 24 h. These findings suggest that acute effects of MDMA on immune system are mainly mediated by its interaction with the serotonin transporter and subsequent serotonin release with a possible participation of other neuroendocrine regulatory systems.


Received October 9, 2003; accepted December 10, 2003.

Address correspondence to: Dr. Rafael de la Torre, Institut Municipal d'Investigació Mèdica, Doctor Aiguader 80, E-08003 Barcelona, Spain. E-mail: rtorre{at}imim.es




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. D Verrico, L. Lynch, M. A Fahey, A.-K. Fryer, G. M Miller, and B. K Madras
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor
J Psychopharmacol, March 1, 2008; 22(2): 187 - 202.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Farre, S. Abanades, P. N. Roset, A. M. Peiro, M. Torrens, B. O'Mathuna, M. Segura, and R. de la Torre
Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 954 - 962.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G. J. H. Dumont and R. J. Verkes
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
J Psychopharmacol, March 1, 2006; 20(2): 176 - 187.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. J. Connor, A. Harkin, and J. P. Kelly
Methylenedioxymethamphetamine Suppresses Production of the Proinflammatory Cytokine Tumor Necrosis Factor-{alpha} Independent of a {beta}-Adrenoceptor-Mediated Increase in Interleukin-10
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 134 - 143.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.